Risk of intravenous amiodarone in patients with atrial fibrillation and ventricular preexcitation

Pacing Clin Electrophysiol. 2021 Mar;44(3):566-567. doi: 10.1111/pace.14176. Epub 2021 Feb 3.

Authors

Laszlo Littmann¹, H James Norton²

Affiliations

¹ Department of Internal Medicine, Atrium Health - Carolinas Medical Center, Charlotte, North Carolina, USA.
² Professor Emeritus, Department of Biostatistics, Atrium Health - Carolinas Medical Center, Charlotte, North Carolina, USA.

PMID: 33491814
DOI: 10.1111/pace.14176

No abstract available

Publication types

Letter
Comment

MeSH terms

Amiodarone* / adverse effects
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / drug therapy
Humans
Pre-Excitation Syndromes*

Substances

Anti-Arrhythmia Agents
Amiodarone